Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

792 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transcranial alternating current stimulation for neuropsychiatric disorders: a systematic review of treatment parameters and outcomes.
Gholamali Nezhad F, Martin J, Tassone VK, Swiderski A, Demchenko I, Khan S, Chaudhry HE, Palmisano A, Santarnecchi E, Bhat V. Gholamali Nezhad F, et al. Among authors: bhat v. Front Psychiatry. 2024 Aug 14;15:1419243. doi: 10.3389/fpsyt.2024.1419243. eCollection 2024. Front Psychiatry. 2024. PMID: 39211537 Free PMC article.
Neuromodulatory treatments for psychiatric disease: A comprehensive survey of the clinical trial landscape.
Elias GJB, Boutet A, Parmar R, Wong EHY, Germann J, Loh A, Paff M, Pancholi A, Gwun D, Chow CT, Gouveia FV, Harmsen IE, Beyn ME, Santarnecchi E, Fasano A, Blumberger DM, Kennedy SH, Lozano AM, Bhat V. Elias GJB, et al. Among authors: bhat v. Brain Stimul. 2021 Sep-Oct;14(5):1393-1403. doi: 10.1016/j.brs.2021.08.021. Epub 2021 Aug 27. Brain Stimul. 2021. PMID: 34461326 Free article. Review.
Baseline anxiety, and early anxiety/depression improvement in anxious depression predicts treatment outcomes with escitalopram: A CAN-BIND-1 study report.
Khoo Y, Demchenko I, Frey BN, Milev RV, Ravindran AV, Parikh SV, Ho K, Rotzinger S, Lou W, Lam RW, Kennedy SH, Bhat V; CAN-BIND Investigator Team. Khoo Y, et al. Among authors: bhat v. J Affect Disord. 2022 Mar 1;300:50-58. doi: 10.1016/j.jad.2021.12.027. Epub 2021 Dec 15. J Affect Disord. 2022. PMID: 34921820
Cerebello-cerebral Functional Connectivity Networks in Major Depressive Disorder: a CAN-BIND-1 Study Report.
Anteraper SA, Guell X, Lee YJ, Raya J, Demchenko I, Churchill NW, Frey BN, Hassel S, Lam RW, MacQueen GM, Milev R, Schweizer TA, Strother SC, Whitfield-Gabrieli S, Kennedy SH, Bhat V; CAN-BIND Investigator Team. Anteraper SA, et al. Among authors: bhat v. Cerebellum. 2023 Feb;22(1):26-36. doi: 10.1007/s12311-021-01353-5. Epub 2022 Jan 13. Cerebellum. 2023. PMID: 35023065
Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy.
Espinola CW, Khoo Y, Parmar R, Demchenko I, Frey BN, Milev RV, Ravindran AV, Parikh SV, Ho K, Rotzinger S, Lou W, Lam RW, Kennedy SH, Bhat V; CAN-BIND Investigator Team. Espinola CW, et al. Among authors: bhat v. Brain Behav. 2022 May;12(5):e2555. doi: 10.1002/brb3.2555. Epub 2022 Mar 25. Brain Behav. 2022. PMID: 35333448 Free PMC article.
Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report.
Espinola CW, Khoo Y, Parmar R, Demchenko I, Frey BN, Milev RV, Ravindran AV, Parikh SV, Ho K, Rotzinger S, Lou W, Lam RW, Kennedy SH, Bhat V. Espinola CW, et al. Among authors: bhat v. J Psychopharmacol. 2022 May;36(5):604-613. doi: 10.1177/02698811221095832. Epub 2022 May 12. J Psychopharmacol. 2022. PMID: 35546043 Clinical Trial.
792 results